Please login to the form below

Not currently logged in
Email:
Password:

Talen

This page shows the latest Talen news and features for those working in and with pharma, biotech and healthcare.

Trial dents confidence in Sangamo’s gene-editing tech

Trial dents confidence in Sangamo’s gene-editing tech

alternative to other methods such as CRISPR and TALEN for in vivo gene editing.

Latest news

More from news
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest Intelligence

  • 2019: CRISPR and therapeutic gene editing comes of age 2019: CRISPR and therapeutic gene editing comes of age

    Before CRISPR, the introduction of zinc-finger nucleases (ZFNs) and TALE nucleases (TALENs) in the genome engineering toolbox has already allowed gene manipulation in additional higher organisms such as human cells. ... TALENs work in a similar way to

  • Cutting through the noise: CRISPR Cutting through the noise: CRISPR

    But other technologies are still very much in play. Chief among these are zinc-finger nucleases (ZFNs), and transcription activator-like effector nucleases (TALEN). ... Cell therapy company Cellectis remains an exponent of TALEN, while Bluebird is using

More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics